Navegando por Palavras-chave "SS-A/Ro"

Agora exibindo 1 - 2 de 2
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Autoantibodies to 60 kDa SS-A/Ro yield a specific nuclear myriad discrete fine speckled immunofluorescence pattern
    (Elsevier B.V., 2013-04-01) Dellavance, Alessandra; Alvarenga, Rossana Rassi [UNIFESP]; Rodrigues, Silvia Helena [UNIFESP]; Barbosa, Silvia Helena; Pinto Camilo, Amandia Cristina; Okamoto Shiguedomi, Herika Santiago; Rodrigues, Silvia Sanchez; Silva, Cristiane Gallindo; Coelho Andrade, Luis Eduardo [UNIFESP]; Fleury Med & Hlth Labs; Universidade Federal de São Paulo (UNIFESP)
    Objectives: To report on a novel immunofluorescence pattern specifically associated with antibodies to SS-A/Ro.Methods: A novel immunofluorescence pattern, herein designated SS-A/Ro pattern, was characterized as myriad discrete fine speckles throughout the nucleus. Eighty-six sequential samples presenting the SS-A/Ro pattern and 64 samples presenting non-SS-A/Ro nuclear fine speckled pattern at the ANA-HEp-2 routine were screened for SS-A/Ro reactivity. Conversely, 48 samples with known reactivity to 60 kDa SS-A/Ro, 13 samples with exclusive reactivity to 52 kDa SS-A/Ro, and 48 SS-A/Ro-negative samples were analyzed for the ANA-HEp-2 pattern.Results: Eighty-five of the 86 samples (98.8%) presenting the SS-A/Ro pattern and 15 of the 64 (23.4%) samples with non-SS-A/Ro fine speckled pattern reacted with 60 kDa SS-A/Ro. Conversely, 44 (91.6%) of 48 samples with known reactivity to 60 kDa SS-A/Ro presented the SS-A/Ro pattern and four (8.4%) presented non-SS-A/Ro fine speckled pattern. None of the 48 anti-SS-A/Ro-negative samples and none of anti-52 kDa SS-A/Ro-positive samples yielded the SS-A/Ro pattern. This immunofluorescence pattern was observed in different commercial HEp-2 cell slides and in homemade HEp-2 cell slides.Conclusions: the SS-A/Ro pattern belongs to the group of immunofluorescence patterns that hold strong association with the respective autoantibody specificities, such as those associated with CENP-F and NuMA-1. the identification of the SS-A/Ro pattern at the ANA-HEp-2 screening routine shall lead to specific tests for the identification of anti-SS-A/Ro antibodies. (C) 2013 Elsevier B.V. All rights reserved.
  • Imagem de Miniatura
    Item
    Embargo
    Estudo da expressão dos auto-antígenos SS-A/Ro (polipeptídeos 52kda e 60kda) e SS-B/La (polipeptídeo 48kda) e de seus RNAs mensageiros em glândulas salivares menores de pacientes com síndrome de Sjögren
    (Universidade Federal de São Paulo (UNIFESP), 2006-12-31) Silveira, Karin Spat Albino Barcellos [UNIFESP]; Andrade, Luiz Eduardo Coelho [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)
    Purpose: The strong association between primary Sjögren syndrome (pSS) and autoantibodies to SS-A/Ro (52kDa and 60kDa) and SS-B/La may be indicative of a possible role for these autoantigens in the pathophysiology of the disease. The present study aimed to analyze protein and mRNA expression of SS-A/Ro and SS-B/La antigens in a preferential tissue target of pSS, i.e., minor salivary glands (MSGs). Methods: SS-A/Ro (60kDa & 52kDa) and SS-B/La protein expression was studied by immunohistochemistry in MSG samples of 26 pSS patients and 16 control subjects. Analysis was carried out by two independent blinded observers according to the topography and intensity (semiquantitative score) of the staining. Total RNA extracted from MSG samples of 10 pSS patients and 7 control subjects was submitted to reverse transcription and quantified by Real Time PCR with primers specific to SS-A/Ro (60kDa & 52kDa) and SS-B/La cDNA. Samples were normalized by ß-actin and GAPDH mRNA expression. Relative mRNA expression (2-ΔΔCT) was compared between pSS patients and control subjects. Results: In general the semiquantitative protein expression for the three autoantigens did not differ among pSS patients and control subjects, and was more prominent in the cytoplasm as compared to the nucleus in all cell types. However, SS-B/La protein had higher expression in the cytoplasm of ductal cells than in the cytoplasm of mucous acinar cells in pSS patients (p=0.013), while no significant difference was detected in the control group (p=0.704). SS-A/Ro 60kDa protein had higher expression in the cytoplasm of ductal cells than in the cytoplasm of serous acinar cells of pSS patients (p=0.006) but the same was not observed for controls (p=0.156). SS-A/Ro 52kDa protein topographic expression pattern was the same in patients and controls. SS-B/La mRNA expression was higher in samples from pSS patients (5.326±5.107) than in controls (0.856±1.255) (p=0.0311). The same was true for SS-A/Ro 60kDa mRNA expression (6.866±7.868 vs 1.045±1.329; p=0.0330). On the other hand, SS-A/Ro 52kDa mRNA expression showed a modest trend for higher expression in samples from pSS patients but the difference did not reach statistical significance (5.616±4.885 vs 2.648±4.223; p=0.0879). Samples with the highest histological inflammation score at MSG showed decreased expression of SS-A/Ro 60kDa, SS-A/Ro 52kDa and SS-B/La mRNAs. Conclusions: The increased SS-A/Ro 60kDa and SS-B/La mRNA expression in MSGs of pSS patients as well as the differential SS-A/Ro 60kDa and SS-B/La protein expression in ductal cells of MSGs in pSS patients suggest that these antigens are probably involved in triggering and maintaining the tissue-specific autoimmune response in pSS MSGs. The observed differential expression may contribute to the antigen-driven immune response and local autoantibody production in pSS.